Long-term impact of COVID-19 requiring elevated oxygen support and safety of prolonged positive pressure ventilation

Published: 18 October 2023
Abstract Views: 496
PDF: 289
HTML: 75
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.


In this study, we analyzed long-term sequelae in patients hospitalized at Montichiari Hospital (Brescia, Italy) during the COVID-19 acute phase, who needed a high-flow oxygen treatment. The follow-up evaluation has been performed after more than one year from discharge through a quality-of-life phone interview, standard laboratory tests, chest computed tomography, and global spirometry with an evaluation of the diffusing capacity of the lungs for carbon monoxide (DLCO). In our analysis, we found that patients who needed high FiO2 support during the acute phase, independently from the device used to administer it, showed a long-term heavy burden of pulmonary consequences: more than half of patients presented radiological alterations and persistent dyspnea or DLCO alterations; about 17% of them had alterations compatible with pulmonary fibrosis. Further analysis included a comparison of long-term consequences in patients treated with different devices. An interesting result was that prolonged positive pressure ventilation treatment didn’t seem to cause persistent pulmonary damage and thus could be considered a safe approach. In conclusion, this study confirms the heavy quality-of-life impact of moderate to severe COVID-19 and highlights the importance of recognizing patients who will benefit from rehabilitative programs and customized follow-up depending on the acute phase disease severity.



PlumX Metrics


Download data is not yet available.


Raveendran AV, Jayadevan R, Sashidharan S. Long COVID: An overview. Diabetes Metab Syndr Clin Res Rev 2021;15:869-75. DOI: https://doi.org/10.1016/j.dsx.2021.04.007
World Health Organisation. A clinical case definition of post COVID-19 condition by a Delphi consensus data. 2021. Available from: WHO/2019-NCoV/Post_COVID-19_condition/Clinical_case_definition/2021.1 (accessed on 23th December 2021)
Kewalramani N, Heenan K, McKeegan D, Chaudhuri N. Post-COVID Interstitial Lung Disease—The Tip of the Iceberg. Immunol Allergy Clin N Am 2023;43:389-410. DOI: https://doi.org/10.1016/j.iac.2023.01.004
Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis 2021;53:737-54. DOI: https://doi.org/10.1080/23744235.2021.1924397
Ahmad MS, Shaik RA, Ahmad RK, et al. “LONG COVID”: An insight. Eur Rev Med Pharmacol Sci 2021;25:5561-77.
Tanni SE, Fabro AT, de Albuquerque A, et al. Pulmonary fibrosis secondary to COVID-19: a narrative review. Expert Rev Respir Med 2021;15:791-803. DOI: https://doi.org/10.1080/17476348.2021.1916472
Leidi F, Boari GEM, Scarano O, et al. Comparison of the characteristics , morbidity and mortality of COVID-19 between first and second/third wave in a hospital setting in Lombardy : a retrospective cohort study. Intern Emerg Med 2022;17:1941-9 DOI: https://doi.org/10.1007/s11739-022-03034-5
Sandhu P, Shah AB, Ahmad FB, et al. Emergency Department and Intensive Care Unit Overcrowding and Ventilator Shortages in US Hospitals During the COVID-19 Pandemic, 2020-2021. Public Health Rep 2022;137:796-802. DOI: https://doi.org/10.1177/00333549221091781
Brusasco C, Corradi F, Di Domenico A, et al. Continuous positive airway pressure in COVID-19 patients with moderate-to-severe respiratory failure. Eur Respir J 2021;57:2002524. DOI: https://doi.org/10.1183/13993003.02524-2020
Duca A, Memaj I, Zanardi F, et al. Severity of respiratory failure and outcome of patients needing a ventilatory support in the Emergency Department during Italian novel coronavirus SARS-CoV2 outbreak: Preliminary data on the role of Helmet CPAP and Non-Invasive Positive Pressure Ventilati. EClinicalMedicine 2020;24:1-7. DOI: https://doi.org/10.1016/j.eclinm.2020.100419
Vitacca M, Nava S, Santus P, Harari S. Early consensus management for non-ICU acute respiratory failure SARS-CoV-2 emergency in Italy: From ward to trenches. Eur Respir J 2020;55. DOI: https://doi.org/10.1183/13993003.00632-2020
Boari GEM, Bonetti S, Braglia-Orlandini F, et al. Short- Term Consequences of SARS-CoV-2-Related Pneumonia: A Follow Up Study. High Blood Press Cardiovasc Prev 2021;28:373-81. DOI: https://doi.org/10.1007/s40292-021-00454-w
Arnold DT, Hamilton FW, Milne A, et al. Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: Results from a prospective UK cohort. Thorax 2021;76:399-401. DOI: https://doi.org/10.1136/thoraxjnl-2020-216086
Huang C, Huang L, Wang Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. The Lancet 2021;397:220-32. DOI: https://doi.org/10.1016/S0140-6736(20)32656-8
Stewart I, Jacob J, George PM, et al. Residual Lung Abnormalities after COVID-19 Hospitalization: Interim Analysis of the UKILD Post–COVID-19 Study. Ame J Respir Critical Care Med 2023;207:693-703. DOI: https://doi.org/10.1164/rccm.202203-0564OC

How to Cite

Salvotti, F., Pellegrinelli, R., Geroldi, V., Leidi, F., Scipione, V., Flamminio, G., Pastori, A., Agabiti-Rosei, C., De Ciuceis, C., Rizzoni, D., & Boari, G. E. M. (2023). Long-term impact of COVID-19 requiring elevated oxygen support and safety of prolonged positive pressure ventilation. Italian Journal of Medicine, 17(3). https://doi.org/10.4081/itjm.2023.1641